Cargando…

Early extrahepatic recurrence as a pivotal factor for survival after hepatocellular carcinoma resection: A 15-year observational study

BACKGROUND: Surgical resection is one of the most widely used modalities for the treatment of hepatocellular carcinoma (HCC). Early extrahepatic recurrence (EHR) of HCC after surgical resection is considered to be closely associated with poor prognosis. However, data regarding risk factors and survi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoon, Jae Hyun, Choi, Sung Kyu, Cho, Sung Bum, Kim, Hee Joon, Ko, Yang Seok, Jun, Chung Hwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Observational Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521522/ https://www.ncbi.nlm.nih.gov/pubmed/36185633 http://dx.doi.org/10.3748/wjg.v28.i36.5351

Ejemplares similares

Simple parameters predicting extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma
por: Yoon, Jae Hyun, et al.
Publicado: (2021)

Extrahepatic recurrence of hepatocellular carcinoma after curative hepatic resection
por: Byeon, Jangmoo, et al.
Publicado: (2012)

Whole blood viscosity is associated with extrahepatic metastases and survival in patients with hepatocellular carcinoma
por: Han, Ji Won, et al.
Publicado: (2021)

Features of extrahepatic metastasis after radiofrequency ablation for hepatocellular carcinoma
por: Yoon, Jae H, et al.
Publicado: (2020)

Hepatocellular carcinoma, decompensation, and mortality based on hepatitis C treatment: A prospective cohort study
por: Choi, Gwang Hyeon, et al.
Publicado: (2022)

Effect of treating chronic hepatitis C with direct-acting antivirals on extrahepatic cutaneous manifestations
por: El Kassas, Mohamed, et al.
Publicado: (2020)

Patterns of failure and prognostic factors in resected extrahepatic bile duct cancer: implication for adjuvant radiotherapy
por: Koo, Tae Ryool, et al.
Publicado: (2014)

Deep learning-based radiomics based on contrast-enhanced ultrasound predicts early recurrence and survival outcome in hepatocellular carcinoma
por: Huang, Zhe, et al.
Publicado: (2022)

Adenosquamous Carcinoma of the Extrahepatic Bile Duct
por: Gupta, Deepika, et al.
Publicado: (2022)

Hemorrhagic extrahepatic recurrence of hepatocellular carcinoma: A case report
por: Yeow, Gilbert Peh Voon, et al.
Publicado: (2019)

Resection of recurrent third branchial cleft fistulas assisted by flexible pharyngotomy
por: Ding, Xiao-Qiong, et al.
Publicado: (2019)

In Vivo Evidence of Single (13)C and (15)N Isotope–Labeled Methanotrophic Nitrogen-Fixing Bacterial Cells in Rice Roots
por: Hara, Shintaro, et al.
Publicado: (2022)

Outcomes and recurrence pattern after non-anatomic liver resection for solitary hepatocellular carcinomas
por: Cho, Sung Hoon, et al.
Publicado: (2016)

Comparison of the Malignant Predictors in Intrahepatic and Extrahepatic Intraductal Papillary Neoplasm of the Bile Duct
por: Han, Sung Yong, et al.
Publicado: (2022)

Extent of resection for T2N0 gallbladder carcinoma regarding concurrent extrahepatic bile duct resection
por: Gwark, Sung-Chan, et al.
Publicado: (2012)

Competing risk analysis on outcome after hepatic resection of hepatocellular carcinoma in cirrhotic patients
por: Cucchetti, Alessandro, et al.
Publicado: (2017)

Effectiveness of the albumin-bilirubin score as a prognostic factor for early recurrence after curative hepatic resection for hepatocellular carcinoma
por: Lee, Yun Ho, et al.
Publicado: (2018)

Prevalence and outcomes of extrahepatic primary malignancy associated with Hepatocellular Carcinoma in a Korean population
por: Hong, Sukho, et al.
Publicado: (2015)

Radiation therapy for recurrent extrahepatic bile duct cancer
por: Koh, Minji, et al.
Publicado: (2021)

The impact of liver resection on survival outcomes of hepatocellular carcinoma patients with extrahepatic metastases: A propensity score matching study
por: Mao, Kai, et al.
Publicado: (2018)

Fibrinogen-to-albumin ratio predicts overall survival of hepatocellular carcinoma
por: Sun, Hao, et al.
Publicado: (2023)

Comparison of the clinical results of surgical resection for extrahepatic cholangiocarcinomas: Hilar cholangiocarcinoma and mid-to-distal cholangiocarcinoma
por: Jung, Pyung, et al.
Publicado: (2019)

Nivolumab for relapsed/refractory classical Hodgkin lymphoma: 5-year survival from the pivotal phase 2 CheckMate 205 study
por: Ansell, Stephen M., et al.
Publicado: (2023)

Resection of extrahepatic bile ducts with partial hepatectomy for treating intra- and extrahepatic hepatolithiasis
por: Xia, HongTian, et al.
Publicado: (2021)

To Resect or Not to Resect Extrahepatic Bile Duct in Gallbladder Cancer?
por: Gavriilidis, Paschalis, et al.
Publicado: (2017)

Hepatocellular carcinoma recurrence in the extrahepatic bile duct wall: A case report
por: Matsumoto, Taku, et al.
Publicado: (2021)

Expression of Partitioning Defective 3 (Par-3) for Predicting Extrahepatic Metastasis and Survival with Hepatocellular Carcinoma
por: Jan, Yee-Jee, et al.
Publicado: (2013)

Racial/ethnic disparities in hepatocellular carcinoma treatment and survival in California, 1988-2012
por: Stewart, Susan L, et al.
Publicado: (2016)

Patterns of locoregional recurrences and suggestion of the clinical target volume in resected perihilar extrahepatic cholangiocarcinoma
por: Park, Younghee, et al.
Publicado: (2023)

Barcelona clinic liver cancer-stage C hepatocellular carcinoma: A novel approach to subclassification and treatment
por: Jun, Chung Hwan, et al.
Publicado: (2017)

Double-Stent System with Long Duodenal Extension for Palliative Treatment of Malignant Extrahepatic Biliary Obstructions: A Prospective Study
por: Gwon, Dong Il, et al.
Publicado: (2018)

Liver resection for hepatocellular carcinoma larger than 10 cm: A multi-institution long-term observational study
por: Lee, Chao-Wei, et al.
Publicado: (2021)

Comparison of the impact of endoscopic retrograde cholangiopancreatography between pre-COVID-19 and current COVID-19 outbreaks in South Korea: Retrospective survey
por: Kim, Kook Hyun, et al.
Publicado: (2021)

Comparison of the Effects of Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma between Patients with and without Extrahepatic Metastases
por: Yoo, Jeong-Ju, et al.
Publicado: (2014)

Tumor Response to Transcatheter Arterial Chemoembolization in Recurrent Hepatocellular Carcinoma after Living Donor Liver Transplantation
por: Ko, Heung-Kyu, et al.
Publicado: (2007)

Different Survival of Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma Patients by the Extent of Portal Vein Invasion and the Type of Extrahepatic Spread
por: Sinn, Dong Hyun, et al.
Publicado: (2015)

Recurrent nevi: report of three cases with dermatoscopic-dermatopathologic correlation
por: Tschandl, Philipp
Publicado: (2013)

Inflammation-related nomogram for predicting survival of patients with unresectable hepatocellular carcinoma received conversion therapy
por: Wu, Jia-Lin, et al.
Publicado: (2023)

Transarterial chemoembolization for advanced hepatocellular carcinoma without macrovascular invasion or extrahepatic metastasis: analysis of factors prognostic of clinical outcomes
por: Kim, Ji Hoon, et al.
Publicado: (2023)

Drug-eluting beads transarterial chemoembolization sequentially combined with radiofrequency ablation in the treatment of untreated and recurrent hepatocellular carcinoma
por: Zhang, Yan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_56hs7d5um2qkjsfr0jnma5ilgv